The vector of anti-SSX2 T cell receptor (TCR) is constructed for the engineering of T cell to target Human SSX2. The T cells are genetically modified through transduction with a lentiviral vector expressing SSX2-specific T cell receptor. And the vector product was designed for the treatment of Synovial sarcoma.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|VP-TCR-C496||Lenti-SSX2 Murinized T cell receptor Viral Particle|
|VP-TCR-C495||Lenti-SSX2 T cell receptor (TCR5) Viral Particle|
|TCR-L107||Murinized (from Human) anti-SSX2 (KASEKIFYV) T Cell Receptor, pMSGV1|
|TCR-L106Z||Murinized anti-SSX2 (aa41-49) T cell receptor, pCDTCR1|
|TCR-C240Z||Murinized anti-SSX2 T cell receptor (TCR5), pCDTCR1|
|VP-TCR-C497||Lenti-SSX2 T cell receptor Viral Particle|
Copyright © 2007 - 2017 Creative Biolabs. All Rights Reserved